ConserV Bioscience

At Conserv, we are delighted to be a member of the Flavivaccine consortium and to work with our international colleagues on this ground-breaking project.

We are happy to be part of an excellent consortium led by Julien Pompon of the INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT awarded a Horizon Europe grant for the evaluation of a novel pan-flavivirus vaccine which further expands our mosquito platform. The grant will fund the development of a vaccine incorporating novel antigen strategies targeting all mosquito-borne flaviviruses. #vaccinedevelopment #innovation

We are excited to work with our colleagues at the University of Leeds Clive McKimmie and KU Leuven Leen Delang to advance the development of our new arbovirus platform, ARBO-SAL, under grant funding provided by Innovate UK. ARBO-SAL expands our mosquito platform to specifically target #zika, #chikungunya and other mosquito-borne arboviruses. #vaccinedevelopment #innovation https://bit.ly/arbo_sal

We are excited to work with our colleagues at the University of Maryland School of Medicine Matthew Frieman to advance the development of UNICOR-v, our pan-coronavirus vaccine under a grant award provided by Innovate UK. We aim to generate protective immune responses against all coronaviruses including those from alpha, beta, delta and gamma genera, not just the recent pandemic strains. #coronavirus #vaccinedevelopment #innovation https://lnkd.in/ehKwJgUx

We are excited to work with our colleagues at Walter Reed Army Institute of Research to advance a novel malaria vaccine. Grant funding is provided by the Peer Reviewed Medical Research Program of the Congressionally Directed Medical Research Programs (CDMRP). The candidate includes mosquito saliva antigens and pre-erythrocytic antigens in a combined vaccination strategy. #malariaprevention #vaccinedevelopment #innovation https://lnkd.in/ePwAz93h

2023 was a productive year for ConserV. We were awarded 4 grants our of 4 applications, a 100% hit ratio. These grants will help us advance several vaccine canidates and generate new IP. Well done team and thank you to our partners and consortia members! #2023success #vaccinedevelopment #malaria #coronavirus #zika #chikungunya

We at Heyford Park Innovation Centre are pleased to see our customer ConserV Bioscience reach their 3rd anniversary, congratulations to the team for all their hard work!   Read more about ConserV here - https://lnkd.in/e6NR8Sa9 #innovation #business #laboratory #success #science